☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
taiho oncology
Insights+: The US FDA New Drug Approvals in August 2023
September 21, 2023
Taiho Oncology and Taiho Pharmaceutical Receive the US FDA’s Approval of Lonsurf (trifluridine/tipiracil) for Adult with Metastati...
August 3, 2023
Taiho Oncology Reports the US FDA Acceptance of sNDA for Priority Review of Lonsurf (trifluridine and tipiracil) for Refractory Me...
April 19, 2023
Taiho Oncology Publishes P-II Trial (FOENIX*-CCA2) Results of Futibatinib for Metastatic Intrahepatic Cholangiocarcinoma in NEJM
January 19, 2023
Taiho Oncology Reports the US FDA’s Acceptance of NDA for Priority Review of Futibatinib for the Treatment of Cholangiocarcinoma
March 31, 2022
PharmaShots Weekly Snapshots (April 05 - 09, 2021)
April 9, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.